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Abstract 
Background: Atopic allergy is a widespread disease with increasing prevalence in the second half of the twentieth 
century and is most often associated with clinical symptoms, like rhinoconjunctivitis, asthma or eczema. This study 
explored the prevalence of atopy and polysensitization in nine cohorts of Swiss medical students during the period 
of 2007–2015. Furthermore, the self-reported allergic symptoms, such as rhinoconjunctivitis, asthma and eczema, 
among students with and without atopy were assessed.
Methods: Each cohort was assessed in the third study year. Students underwent an ImmunoCAP rapid test, a qualita-
tive point-of-care test, and completed an anonymous questionnaire on age, gender and clinical symptoms including 
rhinoconjunctivitis, asthma and eczema. Statistical analyses assessed the overall prevalence of atopy in each group 
and estimated the average annual increase using a linear mixed model. We examined the frequency of occurrence of 
polysensitization and differences of reported symptoms among students with and without atopy.
Results: Data of 1513 students (mean age 22.4–23.3 years across cohorts) in nine cohorts (median cohort size 215 
interquartile range IQR 193–222) were available for analysis. Test results consistent with atopy were present in 39.9% 
of students. Average increase of atopy over the 9 years of observation was 2.25% (95% CI 0.18–4.31%; p = 0.037). Main 
drivers for this increase were the ubiquitously available allergens, house dust mite, timothy grass and birch pollen. 
Atopy and polysensitization were more pronounced in male students: Polysensitization also increased in the observa-
tion period. The clinical symptoms, rhinoconjunctivitis, asthma and eczema were reported by 463 (76.7%) atopic and 
by 141 (15.5%) non-atopic students.
Conclusions: We observed a slight increase of atopy and polysensitization within 9 years of observation in Swiss med-
ical students. The most frequent sensitization occurred with allergens with the highest chance of exposure. Rhinocon-
junctivitis, asthma and eczema are a symptom complex associated with atopy but also found in non-atopic students.
Trial registration retrospectively registered by the Cantonal Ethics Committee Zurich on 22.01.2016; Nr: 08-2016
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Background
Atopic allergies belong to the most common diseases in 
the western world and their prevalence in the adult pop-
ulation in central and northern Europe and the United 
states ranges from about 30% to almost 50% [1–3].
Development of allergies is associated with genetic and 
environmental factors [4–12].
While atopy increased markedly in the second half of 
the twentieth century, [13–18] the development of atopy 
prevalence has been controversially discussed in recent 
years. Whereas some studies noted a plateauing of this 
trend for children and adolescents, [19–21] other data 
documented a further slight increase of atopy prevalence 
[2, 12, 22, 23]. The mechanism leading to these discord-
ances remains unclear.
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In this study we hypothesised that the observed varia-
tion was due to the composition of different risk profiles 
for sensitization of participants that were analysed in 
the various studies. To examine this hypothesis, the aim 
of this study was to document the time course of sensi-
tization and polysensitization in a more homogenous 
selected young adult population with a probable accu-
mulation of risk factors for allergic disorders including 
higher socio-economic status, good education and urban 
life [9, 11, 12]. We analyzed the temporal trend of atopy 
prevalence, sensitization/polysensitization pattern and 
associated clinical symptoms of 1683 Swiss medical stu-
dents from nine 3rd year cohorts between 2007 and 2015.
Methods
The local Ethical Review Board of Zurich assessed the 
protocol of this study and offered a waiver (#8-2016). The 
study strictly adhered to the principles of good clinical 
practice and the ethical standards outlined in the Dec-
laration of Helsinki [24]. The reporting guidelines for 
observational studies (STROBE) were applied [25]. All 
participants were verbally informed and gave their oral 
informed consent when in handing in the questionnaire 
and their blood test results.
Participants
From 2007 to 2015, all third year medical students at 
the University of Zurich attended the practical course 
in immunology and were included, forming nine annual 
cohorts. No exclusion criteria were imposed. In Swit-
zerland, medical students usually study for 6 years after 
completing secondary school at an age of 18  years on 
average. Zurich University has the largest medical school 
in Switzerland with about 220 students per clinical year 
(followed by Berne, Basel and Lausanne). About 10% of 
the students come from abroad. The number of inhabit-
ants living in the catchment area for medical students at 
the University of Zurich is approximately 3 million. This 
corresponds to about 40 percent of the Swiss population. 
The proportion of female students has steadily increased 
and surpassed the 50% margin in 2009.
Data collection
From all participants we secured information on age, 
gender and clinical symptoms, including rhinoconjunc-
tivitis, asthma and eczema. Each student tested his or 
her blood during the practical course in immunology 
using the ImmunoCAP Rapid test kit, a semi-quantitative 
point-of-care test (Thermo Fisher Scientific Inc, Waltham 
MA, USA) according to the manufacturer’s instructions 
and a short film sequence (http://www.phadia.com/
en/Products/Allergy-testing-products/ImmunoCAP-
Rapid). In addition, senior staff of the University Clinic 
for Immunology supervised the testing. We entered 
anonymised personal data and the results from blood 
tests into an electronic database for statistical analysis.
Specific IgE antibodies against the 10 common aeroal-
lergens cat dander (e1), birch (t3, Betula verrucosa), mug-
wort (w6, Artemisia vulgaris), timothy grass (g6, Phleum 
pratense), cockroach (i6, Blatella germanica), dog dan-
der (e5), olive (t9, Olea europaea), wall pellitory (w21, 
Parietaria judaica), house dust mite (d1, Dermatopha-
goides pteronyssinus) and mould (m6, Alternaria alter-
nata) were measured. The 2007 test (ImmunoCAP Rapid 
wheeze/rhinitis child) contained egg white (f1) and cow’s 
milk (f2) instead of cockroach and mould.
Definition of sensitization and allergic diseases
We define atopy as a sensitization to any of the tested 
allergens, monosensitization as sensitization to only one 
allergen, and polysensitization as sensitization to two or 
more of the tested allergens. Sensitization to olive pollen 
was interpreted as a sensitization to ash pollen due to a 
cross-reaction of the sIgE antibodies [26].
We evaluated the frequency of the most common 
IgE-mediated allergic diseases, namely rhinoconjuncti-
vitis, asthma and eczema [27]. The occurrence of atopic 
diseases was assessed by self-reported answers to the 
questions: “Do you suffer from seasonal/perennial rhi-
noconjunctivitis, asthma or eczema?”. We expected that 
3rd  year medical students have the required medical 
knowledge to answer these questions.
Statistical analysis
Interval scaled variates were summarized with means and 
standard deviations or medians and interquartile ranges 
(IQR), where appropriate. Dichotomous variates were 
described as ratios and percentages. We assumed that 
the composition of students from rural and urban areas 
and the average socioeconomic status remained constant 
during the observation period. Under this premise, the 
nine cohorts were combined for further analysis and an 
indicator variate was created for each cohort.
The overall prevalence of atopy in each cohort and 
the average annual increase was assessed using a lin-
ear mixed model allowing a random intercept for each 
cohort. In exploratory analyses we then assessed the tem-
poral changes of ten individual allergens.
We performed all analyses using the Stata 14.2 statistics 
software package (StataCorp LP, College Station, TX, USA).
Results
From 1683 third-year medical students, the question-
naire and the ImmunoCAP Rapid test result was avail-
able in 1513 participants (89.9% of the study population). 
The median cohort size were 215 students, (interquartile 
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range 193–222) and the proportion of female students 
ranged from 43.7–62.2%. Mean age ranged from 22.4 to 
23.3 years. In ten students, data about gender was missing.
Comparison of cohorts
Atopy was present in 604 (39.9%) participants. The most 
common allergen in our study population was timothy 
grass, with a prevalence of 27.5%, followed by house dust 
mite 17.5%, birch 15.3%, olive/ash 11.8% and cat dan-
der 7%. Sensitization to mugwort, alternaria, parietaria, 
dog dander and cockroach were less common, with rates 
below 3% for each. More men than women were atopic 
(odds ratio (OR) 1.53 (95% CI 1.24–1.89), p  <  0.001). 
Accordingly, males were significantly more sensitized 
against birch, timothy grass, olive/ash and house dust 
mite. Of all tested subjects, 22.8% (n =  345) were poly-
sensitized and 17.1% (n  =  259) monosensitized. Male 
subjects were significantly more polysensitized than 
females (see Tables 1, 3).
From the 604 atopic students, 76.6% were symptomatic 
of allergic-related disorders, such as rhinoconjunctivitis, 
asthma or eczema. The most frequent clinical symptom 
was seasonal rhinoconjunctivitis (68.2%), followed by 
asthma (20.8%), eczema (17.9%) and perennial rhino-
conjunctivitis (9.4%). From the 909 non-atopic students, 
16.9% reported seasonal rhinoconjunctivitis, 3.6% peren-
nial rhinoconjunctivitis, 5.7% asthma and 12.4% eczema 
(Table 2).
Time trends
Overall, we observed an average annual 2.25% increase of 
sensitization (95% CI 2.13–2.36%), p < 0.001. House dust 
mite, timothy grass- and birch-pollen were responsible 
for the overall increase. For details, see Fig.  1. The pro-
portion of polysensitization slightly increased during the 
9 years of observation and was more pronounced in male 
subjects compared to women (Table 3; Fig. 2).
Discussion
In this selected population of Swiss, 3rd  year medical 
students, we were able to document a slight increase of 
sensitization and polysensitization for common aeroal-
lergens during the 9 years of observation. Timothy grass 
pollen, house dust mites and tree pollen are the most 
prevalent allergens and they were the main drivers for the 
overall increase of sensitization in the described study-
population. Compared to cohorts in northern Europe, 
prevalence of cat dander sensitivity is relatively low. The 
extent of sensitization in our cohort corresponds to the 
results found in Germany, the USA, and previous Swiss 
studies [2, 3, 23, 28, 29]. This is most probably due to cli-
matic distinctions and exposure frequency.
While atopy increased markedly in the second half 
of the twentieth century, [13, 16–18] data about atopy 
prevalence have been more controversial in recent years. 
Some studies indicate a flattening and stabilization of 
atopy prevalence in Switzerland and other westernized 
countries [19–21, 30] whereas other data noted a further 
increase [12, 23, 31]. Our study describes a selected pop-
ulation of highly educated young adults, living predomi-
nantly in urban areas with a high social status. All these 
factors are described to have the potential to increase 
the risk of developing atopy and allergic diseases [9, 11, 
12, 23, 32]. This exposure to several risk factors might 
explain the slight increase of atopy prevalence in our 
cohorts over 9 years.
The atopy prevalence of 39.9% and the gender distribu-
tion with male subjects suffering more often from atopy 
Table 1 Results from the ImmunoCAP rapid test: fre-
quency of atopy and sensitization to different allergens 
and distribution of non-, mono- and poly-sensitized par-
ticipants
Gender information was missing in ten students
Prevalence
n = 1513
Women
n = 856
Men
n = 647
Missing
n = 10
Atopy 604 (39.9%) 305 (35.6%) 297 (45.9%) 2
Monosensitization 259 (17.1%) 134 (15.7%) 124 (19.2%) 1
Polysensitization 345 (20.5%) 171 (18.1%) 173 (26.7%) 1
 Two allergens 128 (8.5%) 67 (7.8%) 61 (9.4%)
 Three allergens 111 (7.3%) 55 (6.4%) 56 (8.7%)
 ≥ 4 allergens 106 (7.0%) 49 (5.7%) 56 (8.7%) 1
Cat dander (e1) 106 (7.0%) 64 (7.5%) 41 (6.3%) 1
Birch (t3) 231 (15.3%) 106 (12.4%) 124 (19.2%) 1
Mugwort (w6) 42 (2.8%) 23 (2.7%) 19 (2.9%)
Timothy grass (g6) 416 (27.5%) 212 (24.8%) 202 (31.2%) 2
Cockroach (i6) 17 (1.1%) 8 (0.9%) 9 (1.4%) 0
Dog dander (e5) 25 (1.7%) 17 (2.0%) 8 (1.2%) 0
Olive (t9) 179 (11.8%) 86 (10.1%) 93 (14.4%) 0
Parietaria (w21) 29 (1.9%) 12 (1.4%) 17 (2.6%) 0
House dust mite (d1) 265 (17.5%) 127 (14.8%) 137 (21.2%) 1
Mold (Alternaria, m6) 28 (1.9%) 13 (1.5%) 15 (2.7%) 0
Table 2 Comparison of reported symptoms among the 
group of students with vs. without atopy
Subjects 
without atopy 
(n = 909)
Subjects 
with atopy 
(n = 604)
p value
Symptomatic 141 (15.5%) 463 (76.6%) < 0.001
Eczema 17 (12.4%) 83 (17.9%) 0.003
Seasonal rhino-
conjunctivitis
24 (16.9%) 316 (68.2%) < 0.001
Perennial rhino-
conjunctivitis
5 (3.6%) 44 (9.4%) < 0.001
Asthma 8 (5.7%) 96 (20.8%) < 0.001
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and being more often polysensitized than women, is in 
line with other studies from industrialized countries in 
central-, and northern Europe, and the United States 
[2, 3, 28, 29, 33–35]. As documented in other studies, 
polysensitization is more prevalent than monosensiti-
zation [36–38] and more pronounced in men (compare 
Tables  1, 3). Polysensitization is associated with clinical 
manifestation of allergic diseases, especially with asthma 
[38, 39]. Therefore, our findings with an increase of sen-
sitization and polysensitization, in parallel, support an 
overall increase of symptomatic atopic patients in the 
described cohorts.
Rhinoconjunctivitis, asthma and eczema are a com-
plex of disorders, which often coexist and therefore seem 
to have a causal relationship. Normally associated with 
atopy, this symptom complex also occurs in non-atopic 
subjects [40] as shown in Table 2.
Strength and limitations
In this study it was possible to compare cohorts with 
an accumulation of similar risk factors for the develop-
ment of allergic sensitization and related disorders over 
several years. The lack of detailed information about the 
subjects’ genetic background, place of birth, and the time 
point when sensitization and/or allergic symptoms were 
Fig. 1 Overall (upper left) and allergen specific trend across the nine cohorts of students, in percentage of the sensitized population. House dust 
mites, timothy grass- and birch pollen are responsible for the overall increase
Table 3 Proportion of sensitized students who are poly-
sensitized per year cohort and gender
Cohort  
year
Polysensitized  
male among sensitized  
male (%)
Polysensitized female 
among sensitized 
female (%)
2007 14 (42.4) 17 (54.8)
2008 24 (61.5) 16 (53.3)
2009 18 (51.4) 21 (55.3)
2010 8 (42.1) 6 (85.7)
2011 32 (72.7) 33 (60.0)
2012 14 (46.7) 13 (52.0)
2013 21 (67.7) 28 (59.6)
2014 15 (68.2) 9 (42.9)
2015 27 (58.7) 28 (54.9)
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first diagnosed is a downside of this study. Therefore, we 
were unable to explore the extent to which these param-
eters modified the effects reported here. Arguably, spu-
rious differences in the composition of these parameters 
across cohorts, which we were unable to correct in the 
analysis, introduced bias. Nevertheless, due to the lack 
of an obvious mechanism leading to substantial changes 
in the composition of cohorts over time, we consider 
the results valid. Self-reporting of symptoms carry the 
risk of reporting bias. We cannot fully rule-out that such 
bias occurred in our study. On the other hand, it can be 
expected that 3rd year medical students have the neces-
sary medical knowledge to indicate whether they are 
suffering from seasonal/perennial rhinoconjunctivitis, 
asthma or eczema.
Conclusions
Our findings suggest that the trend for an increase in 
atopy prevalence and polysensitization is still on the rise 
in young adults with certain risk factors. Further investi-
gations in selected cohorts with defined risk factors for 
atopic diseases could help to elucidate the mechanisms 
of sensitization. Allergic diseases rhinoconjunctivitis, 
asthma and eczema are associated with atopy but also 
coexist in non-atopic subjects.
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